Dermatology · Alexandria, VA
NPI
1730151119
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4660 Kenmore Ave, Suite 500
Alexandria, VA, 22304
Phone (703) 370-0073
Groups this clinician bills Medicare through
Medicare paid, 2024
$572K
8,464 services
Medicare patients, 2024
1,709
Average age 76
Drug cost, 2024
$781K
1,393 prescriptions
Company payments, 2025
$2,066
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce D Glassman was code 17003 (destruction skin lesion), 2,238 times for 461 patients. In total Bruce D Glassman billed 8,464 services in 83 codes, and Medicare paid $572K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,238 | 461 | $6.08 | $14K |
| 99213 Office E&M - Established | Office | 1,588 | 1,151 | $69.63 | $111K |
| 17000 Destruction Skin Lesion | Office | 1,140 | 764 | $43.07 | $49K |
| 17110 Destruction Skin Lesion | Office | 641 | 553 | $88.11 | $56K |
| 11102 Skin Biopsy | Office | 429 | 355 | $71.42 | $31K |
| 99214 Office E&M - Established | Office | 394 | 310 | $98.98 | $39K |
| 99203 Office E&M - New | Office | 184 | 184 | $82.19 | $15K |
| 12032 Wound Repair - All Levels | Office | 166 | 138 | $181.67 | $30K |
| 11604 Skin Lesion Excision | Office | 137 | 115 | $250.79 | $34K |
| 11400 Skin Lesion Excision | Office | 136 | 127 | $97.72 | $13K |
| 11103 Skin Biopsy | Office | 122 | 81 | $46.58 | $5,683 |
| 99212 Office E&M - Established | Office | 85 | 81 | $46.85 | $3,983 |
| 99204 Office E&M - New | Office | 81 | 81 | $123.30 | $9,987 |
| 11401 Skin Lesion Excision | Office | 57 | 53 | $125.25 | $7,139 |
| 11420 Skin Lesion Excision | Office | 42 | 39 | $99.18 | $4,165 |
By year: 2022 $598K for 8,233 services; 2023 $595K for 8,616 services; 2024 $572K for 8,464 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruce D Glassman prescribed most often to Medicare patients was Triamcinolone Acetonide, with 233 prescriptions and refills. In total Bruce D Glassman wrote 1,393 Medicare prescriptions that cost $781K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 233 | 263 | 157 | $2,212 |
| Ketoconazole Generic | 168 | 178 | 80 | $3,047 |
| Clobetasol Propionate Generic | 149 | 153 | 82 | $8,178 |
| Hydroxyzine Hcl Generic | 120 | 189 | 62 | $1,590 |
| Hydrocortisone Generic | 65 | 65 | 54 | $381 |
| Fluocinonide Generic | 63 | 68 | 44 | $2,055 |
| Clindamycin Phosphate Generic | 52 | 52 | 18 | $1,117 |
| Cephalexin Generic | 43 | 43 | 35 | $691 |
| Mupirocin Generic | 39 | 40 | 28 | $320 |
| Prednisone Generic | 30 | 30 | 15 | $111 |
| Ammonium Lactate Generic | 28 | 41 | 13 | $539 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 23 | 25 | 11 | $1,715 |
| Valacyclovir Valacyclovir Hcl | 23 | 23 | 15 | $590 |
| Silver Sulfadiazine Generic | 20 | 20 | 12 | $240 |
| Doxycycline Monohydrate Generic | 19 | 28 | 15 | $687 |
Brand drugs: 120 claims; generic drugs: 1,273 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce D Glassman $2,066 ($2,066 in general payments such as food, travel and fees) from 19 companies. The largest payer was LEO Pharma Inc. with $405.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 26 | $405 |
| Abbvie Inc. ABBV | 18 | $322 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $255 |
| Genzyme Corporation SNY | 9 | $189 |
| Organon LLC OGN | 4 | $167 |
| Incyte Corporation INCY | 5 | $133 |
| Pfizer Inc. PFE | 4 | $95.57 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $73.8 |
| Janssen Biotech, Inc. JNJ | 3 | $66.26 |
| UCB, Inc. UCB.BR | 3 | $62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.